Article

1 in 3 Cardiovascular Disease Patients Skip the Flu Shot

Approximately one in three patients with atherosclerotic cardiovascular disease skip the flu shot each year despite its effectiveness in lowering the risk of illness and death, shows research presented at AHA's Scientific Sessions. 

1 in 3 Cardiovascular Disease Patients Skip the Flu Shot

(©Satjawat,AdobeStock_272810110)

Approximately one in three patients with atherosclerotic cardiovascular disease skip the flu shot each year despite its effectiveness in lowering the risk of illness and death, shows research presented at the American Heart Association’s (AHA) Scientific Sessions annual meeting that took place this month in Philadelphia (abstract MDP377).

Researchers examined vaccination rates in more than 15,000 patients with ASCVD (aged ≥40 years) who participated in the national Medical Expenditure Panel Survey between 2008 and 2015.

Researchers asked participants whether they received a flu vaccination in the last year and found:

  • 1 in 3 patients had not been vaccinated in the past year (32%, 95% CI: 30.2%, 33.0%)

  • 30% of patients with insurance and a regular source of medical care had not been vaccinated

  • Uninsured, low-income patients had the highest rate of non-vaccination (65%)

“Our study sheds light on key inequalities related to disparities in flu vaccination rates,” said senior author Khurram Nasir, M.D., MPH, MSc, Houston Methodist Hospital, Texas, in an AHA press release. “We hope that flu vaccinations among heart disease patients becomes an integral part of quality of care measures and will facilitate processes to limit these unintended care gaps among the most vulnerable in our society.”

Patients with heart disease are at an increased risk for medical complications or mortality from the flu, so researchers emphasized the need for patient education prior to flu season.

“Cardiologists, primary care doctors and other clinicians need to have a conversation about flu vaccination well in advance of the onset of flu season to encourage patients to have routine follow-up appointments early in the flu season,” said lead study author Gowtham Rama Harsha Grandhi, MBBS, MPH, of MedStar Health, Baltimore, in the AHA press release.

Grandhi added that physicians should offer vaccination as well as walk-in appointments for vaccination at their clinics to further encourage ASCVD patients to get the flu shot.

Due to the fact that patient history was obtained through surveys and not verified with medical records, researchers noted that inaccuracies in patient recall may have influenced study results.

“Future studies should put emphasis on patient and health system factors driving these disparities and practical interventions to overcome these challenges,” Nasir concluded.

For more news from the American Heart Association’s (AHA) 2019 Scientific Sessions, visit our sister site Patient Care Online.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.